Can a smartphone app curb teen suicide risk?
NCT ID NCT06454136
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests a mobile app designed to reduce suicidal thoughts in teenagers. It will enroll 228 teens aged 13-17 who were recently hospitalized for a suicide attempt or have a history of attempts. Participants will use either the experimental app or a standard information app, and researchers will measure changes in suicidal thinking over 12 weeks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- mobile app (OTX-207)
- What this could lead to
- If it works, this could provide a scalable, accessible tool to help teens manage suicidal thoughts after a hospital stay.
- What could go wrong
- This is a small, early pilot study. The app may not reduce suicidal thoughts more than standard care, and results may not apply to all teens.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 228 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
13 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients (of any sex), ages 13 to 17 years 2. Patients who were recently hospitalized and have: 1. attempted suicide or 2. have documented SI and a history of attempted suicide, as verified by the Columbia-Suicide Severity Rating Scale (C-SSRS). Hospitalized is defined as admission to a medical or psychiatric service for further assessment and care including observation units, intensive care or other medical units and psychiatric units. 3. Patient owns a smartphone capable of downloading and running apps 4. Patient is willing and able to complete enrollment procedures 5. Patient and Parent/Guardian are willing to assent/consent to medical record review for one year following randomization to collect suicide attempt data 6. Patient and Parent/Guardian are able to understand the nature of the study and sign documentation of written informed assent (Patient) and consent (Parent/Guardian) 7. Patient and Parent/Guardian understand written and spoken English 8. Patient is willing to agree to release of information to their Parent/Guardian and providers when clinically indicated Exclusion Criteria: 1. Patients who are acutely intoxicated or in detoxification at the time of enrollment 2. Patients who are currently enrolled in other treatment studies for the symptoms and behaviors targeted 3. Patients who are incapable of understanding and following through with the study procedures (e.g., cognitive impairment) 4. Patients with a psychiatric or medical condition or custody arrangement that, in the opinion of the PI, may compromise, interfere, limit, affect or reduce the patient's ability to provide informed consent, complete the study, or may adversely impact the safety of the patient or the integrity of the data. Examples of considerations include terminal illness where death would be anticipated before completing study procedures, active psychosis at the time of assent, severe or unstable medical condition. 5. Patients whose discharge plans include transfer to inpatient care, as confirmed by the index hospitalization discharge summary/plan.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Suicidal ideation are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hartford HealthCare
Hartford, Connecticut, 06106, United States
-
Rhode Island/Bradley Hospital/Brown Health University
Providence, Rhode Island, 02903, United States
-
University of Cincinnati
Cincinnati, Ohio, 45219, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a short, Family-Focused program replace hospital stays for suicidal teens?
- Can a website persuade men in crisis to ask for help?
- Can group therapy help teens with suicidal thoughts?
- Can music soothe the inner pain of a suicidal crisis?
- Can a single shot of ketamine calm suicidal distress in the ER?
- Can a centralized team prevent more suicide attempts?